Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report

Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report

Gallbladder carcinoma (GBC) with proficient mismatch repair (pMMR)/microsatellite stable (MSS) is associated with limited response to programmed death-1 (PD-1) inhibitor monotherapy. Limited data of PD-1 blockade combined with anti-angiogenic therapy in GBC are reported. One recurrent GBC patient wi...

Full description

Bibliographic Details
Main Authors: Liting Zhong, Xiaoyu Liu, Zelei Li, Xuebing Zhang, Yuli Wang, Weiwei Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
gallbladder carcinoma
PD-1 blockade
anti-angiogenic therapy
pMMR/MSS
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.783158/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.783158/full

Similar Items